On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next generation Aquadex SmartFlow system to Austria, following shipments to Germany earlier this year. The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload).

The company has partnered with Neucomed Group and its affiliates to serve patients in Germany, Austria and Switzerland and now has commercial distribution partnerships covering 13 countries worldwide.

CHF Solutions is a medical device company dedicated to improving the lives of patients suffering from fluid overload with its novel ultrafiltration therapy system. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow system for ultrafiltration therapy. CHF Solutions is headquartered in Minneapolis, Minn., with wholly-owned subsidiaries in Australia and Ireland.